ARTA
ACER

A.R.T. Advisors’s Acer Therapeutics Inc ACER Stock Holding History

A.R.T. Advisors’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,673
Closed -$21K – 1802
2017
Q1 		$21K Buy
+2,673
New +$26.3K ﹤0.01% 1372
2016
Q1 		– Sell
-1,147
Closed -$33K – 1720
2015
Q4 		$33K Sell
1,147
-423
-27% -$14K ﹤0.01% 1401
2015
Q3 		$51K Buy
+1,570
New +$55.4K ﹤0.01% 1291

Other funds holding ACER

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

A.R.T. Advisors's ACER Position: Q2 2017 in Review

A.R.T. Advisors sold out of Acer Therapeutics Inc (ACER) in Q2 2017, closing a stake of 2,673 shares — an estimated $21K sold.

A.R.T. Advisors first reported a position in ACER in Q3 2015 and held it in 3 quarters. The position peaked at $51K in Q3 2015. 13 funds tracked by Wall St. Rank hold ACER as of Q2 2017.

  • A.R.T. Advisors reported no remaining Acer Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
  • A.R.T. Advisors sold 2,673 Acer Therapeutics Inc shares in Q2 2017, an estimated $21K.
  • A.R.T. Advisors first reported a position in Acer Therapeutics Inc in Q3 2015 and held it in 3 quarters.
  • A.R.T. Advisors's Acer Therapeutics Inc position peaked at $51K in Q3 2015.
  • 13 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q2 2017.

Based on A.R.T. Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.